EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4+ T cells

[1]  K. Fujio,et al.  Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases , 2018, Front. Immunol..

[2]  Alistair L. J. Symonds,et al.  Egr2 and 3 Inhibit T-bet–Mediated IFN-γ Production in T Cells , 2017, The Journal of Immunology.

[3]  D. Khan,et al.  Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice , 2017, PloS one.

[4]  Kazuhiko Yamamoto,et al.  Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production , 2016, Proceedings of the National Academy of Sciences.

[5]  J. Miyazaki,et al.  TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses , 2015, Nature Communications.

[6]  M. Zhang,et al.  The Roles of Egr-2 in Autoimmune Diseases , 2014, Inflammation.

[7]  W. Leonard,et al.  EGR2 is critical for peripheral naïve T-cell differentiation and the T-cell response to influenza , 2014, Proceedings of the National Academy of Sciences.

[8]  R. Dai,et al.  Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice , 2013, Biology of Sex Differences.

[9]  K. Morris,et al.  Interferon-γ and systemic autoimmunity. , 2013, Discovery medicine.

[10]  Alistair L. J. Symonds,et al.  Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf. , 2013, Journal of immunology.

[11]  Yan Zheng,et al.  Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo , 2012, The Journal of experimental medicine.

[12]  Alistair L. J. Symonds,et al.  The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells , 2012, Immunity.

[13]  Swati Bhattacharyya,et al.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses. , 2011, The American journal of pathology.

[14]  O. Crasta,et al.  Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus , 2010, PloS one.

[15]  C. Hunter,et al.  EGR-2 Is Not Required for In Vivo CD4 T Cell Mediated Immune Responses , 2010, PloS one.

[16]  Y. Okada,et al.  Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. , 2010, Human molecular genetics.

[17]  S. Sakaguchi,et al.  CD4+CD25−LAG3+ regulatory T cells controlled by the transcription factor Egr-2 , 2009, Proceedings of the National Academy of Sciences.

[18]  O. Crasta,et al.  Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. , 2008, Blood.

[19]  Alistair L. J. Symonds,et al.  Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease , 2008, The Journal of experimental medicine.

[20]  N. Kamatani,et al.  Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B1 , 2008, The Journal of Immunology.

[21]  S. Davis,et al.  Distinct Functions of Egr Gene Family Members in Cognitive Processes , 2008, Front. Neurosci..

[22]  O. Crasta,et al.  Suppression of LPS-induced IFN γ and nitric oxide in splenic lymphocytes by select estrogen-regulated miRNA : A novel mechanism of immune modulation , 2008 .

[23]  R. Dai,et al.  Despite Inhibition of Nuclear Localization of NF-κB p65, c-Rel, and RelB, 17-β Estradiol Up-Regulates NF-κB Signaling in Mouse Splenocytes: The Potential Role of Bcl-31 , 2007, The Journal of Immunology.

[24]  Rebecca A. Phillips,et al.  Estrogen selectively regulates chemokines in murine splenocytes , 2007, Journal of leukocyte biology.

[25]  R. Dai,et al.  Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. , 2007, Journal of immunology.

[26]  Jeanne Kowalski,et al.  Egr-2 and Egr-3 are negative regulators of T cell activation , 2005, Nature Immunology.

[27]  M. Czech,et al.  Early Growth Response Gene-2, a Zinc-Finger Transcription Factor, Is Required for Full Induction of Clonal Anergy in CD4+ T Cells1 , 2004, The Journal of Immunology.

[28]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[29]  D. Kono,et al.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity , 2001, Arthritis research.

[30]  K. Blenman,et al.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Ashwell,et al.  Role of Egr-2 in Up-regulation of Fas Ligand in Normal T Cells and Aberrant Double-negative lpr and gld T Cells* , 1999, The Journal of Biological Chemistry.

[32]  A. Schwarting,et al.  IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. , 1998, Journal of immunology.

[33]  B. Ryffel,et al.  IFN-γ Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB × NZW)F1 Mice , 1998, The Journal of Immunology.

[34]  B. Ryffel,et al.  IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. , 1998, Journal of immunology.

[35]  D. Balomenos,et al.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.

[36]  R. Eisenberg,et al.  Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.

[37]  H. Mcdevitt,et al.  In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon , 1987, The Journal of experimental medicine.